Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 128 clinical trials
Neuroinflammation in Alzheimer's Disease

/CT scan visit if the investigator needs to confirm the subject is able to be in the study. A blood sample will be taken before the scans. Additional blood samples will be taken during the PET

amyloid
cognitive impairment
alzheimer's disease
mini-mental state examination
mild cognitive impairment
  • 0 views
  • 25 Jan, 2021
  • 1 location
Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

acalabrutinib at the standard dose twice per day orally. All patients will undergo response assessment at the end of six cycles of R-CHOP + acalabrutinib with CT scan, PET/CT scan, and bone marrow biopsy

  • 0 views
  • 28 Mar, 2021
  • 3 locations
Imaging Immune Activation in COVID-19

in participants with convalescent COVID-19. Up to 20 participants will be enrolled over an accrual period of approximately 24 months. Each participant will undergo one PET-CT scan following 50 +/- 10

  • 0 views
  • 05 Apr, 2021
  • 1 location
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

tomography (PET/CT) in patients with brain cancer or cancer that has spread to the brain (brain metastases). A PET/CT scan is an imaging test that uses a small amount of radioactive tracer (given through the

  • 0 views
  • 28 Mar, 2021
  • 1 location
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

interested to investigate another new imaging technique called PSMA PET/CT. Participants will be invited to undergo a second PET/CT scan, with the PSMA tracer (68Ga-PSMA-11). This is not required but just an

metastasis
pet/ct scan
head and neck cancer
breast cancer
cancer, ovarian
  • 5 views
  • 14 Apr, 2021
  • 2 locations
In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer

or (3) will receive PARP inhibitor therapy as part of their clinical care. A pre-treatment 18F-FluorThanatrace ([18F]FTT) positron emission tomography/computed tomography (PET/CT) scan will

breast ductal carcinoma
adenocarcinoma
pancreatic adenocarcinoma
cancer chemotherapy
pancreatic ductal adenocarcinoma
  • 8 views
  • 26 Jan, 2021
  • 1 location
The Role of Ga68-PSMA-11 PET Imaging in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

> Exclusion criteria: Patient who has any of the following criteria will be excluded from the trial: Unable to tolerate the PET/CT scan, such as those with claustrophobia, unable to lie

metastasis
pet/ct scan
ct scan
bone metastases
antiandrogen therapy
  • 9 views
  • 04 Feb, 2021
  • 1 location
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients

-Anti-HER2 VHH1 with a total mass of up to 200 g NOTA-Anti-HER2 VHH1. Serum and plasma samples will be collected at injection. At 90 min after injection, a total body PET/CT scan will be performed

  • 0 views
  • 25 Jan, 2021
  • 1 location
Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer

intended radiotherapy. In this project all participants have an uPAR-PET/CT scan performed before initiation of the routine radiotherapy and the prognostic efficacy is determined by assessment of the

positron emission tomography
dental caries
metastasis
cancer of the head
ct scan
  • 10 views
  • 25 Jan, 2021
  • 1 location
Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer

experimental group (1:2) and undergo a PSMA PET/CT scan. The experimental group receives individualised therapy based on the result of the PET/CT. The control group receives standard salvage therapy and the

  • 0 views
  • 20 Mar, 2021
  • 3 locations